Telmisartan Is A Common Medication Used To Treat High Blood Pressure

Telmisartan
Telmisartan

Telmisartan is an angiotensin II receptor blocker (ARB). It lowers blood pressure by blocking the action of certain natural substances that tighten the blood vessels. It is used to treat high blood pressure (hypertension). It can help lower risk for heart attack and stroke. It can also help to keep kidneys working well. When blood pressure is high, it can damage the heart and kidneys and increase risk of having a heart attack or stroke.

It works by relaxing blood vessels so that the heart can work more efficiently and the blood can flow more smoothly to different parts of the body. It also lowers the level of salt and water in blood, which helps prevent the buildup of fluid in the lungs and kidneys.

The size of the worldwide Telmisartan Market, which was estimated at US$ 3,880.9 million in 2017, is anticipated to grow at a CAGR of 1.4% from 2018 to 2026.

It is available as 20, 40, and 80 mg tablets. The tablets are usually swallowed whole without chewing or crushing them. The tablets should be stored at room temperature away from moisture and heat.

It is a renin angiotensin system (RAS) inhibitor, which means that it blocks the action of the hormone angiotensin II on special receptors in the body. Angiotensin II normally causes the peripheral blood vessels to narrow, and it also stimulates the production of another hormone called aldosterone.

Telmisartan is metabolized by conjugation to form a pharmacologically inactive glucuronide that is removed from the body via urine. This glucuronide has no effect on plasma concentrations of angiotensin II, renin, or aldosterone and does not have a clinically significant impact on electrolytes.

It is a member of a class of medicines called angiotensin II receptor blockers (ARBs). These medications lower blood pressure by blocking the action of a chemical called Telmisartan that causes the walls of blood vessels to tighten or constrict. A high blood pressure may lead to a heart attack, stroke, kidney failure, and other serious problems.

It has the shortest half-life among ARBs, resulting in rapid and sustained reduction of blood pressure. This is a major advantage over other ARBs such as valsartan, which typically requires a daily oral dose to achieve significant antihypertensive activity.

Control of the early morning blood pressure surge is also an important clinical advantage of Telmisartan. Other benefits include reduced plasma cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride concentrations. In addition, it is able to improve insulin sensitivity and glucose tolerance in people with type 2 diabetes. It is also useful in lowering blood pressure in people with kidney disease or a history of heart failure.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more